Product image of Noradrenalin Kalceks (Norepinephrine) supplied by GNH India

Noradrenalin Kalceks

Active Ingredient:
Norepinephrine
Origin:
EU

Noradrenalin Kalceks (Norepinephrine)

Norepinephrine, the active ingredient in Noradrenalin Kalceks, is a sympathomimetic (catecholamine) presented as an injectable solution for intravenous use. It is employed to raise blood pressure and improve cardiac output in patients with acute hypotension, septic shock, or cardiac arrest.

GNH India supplies Noradrenalin Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to EU GMP standards and providing reliable logistics for critical‑care medicines.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Norepinephrine is a sympathomimetic vasopressor used in critical care to support circulatory function.
  • Acute hypotension: restores systemic blood pressure by inducing peripheral vasoconstriction.
  • Septic shock: counteracts vasodilatory failure and improves organ perfusion.
  • Cardiac arrest: enhances coronary and cerebral blood flow during resuscitation efforts.

How It Works

  • Norepinephrine acts as a direct agonist at alpha‑1 adrenergic receptors, causing potent vasoconstriction, and at beta‑1 receptors, increasing myocardial contractility and heart rate. The combined alpha‑1 and beta‑1 stimulation raises systemic vascular resistance and cardiac output, thereby elevating arterial pressure in states of circulatory collapse.

Side Effects

Norepinephrine may cause a range of adverse reactions, from frequent to rare but serious.

Common Side Effects

  • Tachycardia: rapid heart rate due to beta‑1 stimulation.
  • Hypertension: excessive rise in blood pressure.
  • Headache: secondary to increased vascular tone.
  • Anxiety or restlessness.
  • Peripheral ischemia: reduced blood flow to extremities.
  • Arrhythmias: irregular heart rhythms.

Serious or Rare Side Effects

  • Myocardial ischemia: reduced heart muscle oxygenation.
  • Severe hypertension leading to cerebrovascular events.
  • Tissue necrosis at the infusion site.
  • Pulmonary edema.
  • Cardiac arrest.
  • Life‑threatening bradyarrhythmia.

Precautions & Warnings

  • When using norepinephrine, clinicians should observe several safety measures to minimize risk.
  • Cardiovascular monitoring: continuous blood pressure and heart‑rate tracking is essential.
  • Dose titration: adjust infusion rate to achieve target pressure while avoiding overshoot.
  • Contraindications: avoid in patients with uncorrected pheochromocytoma.
  • Myocardial ischemia caution: use only with careful assessment of cardiac risk.
  • Elderly patients: start at lower infusion rates and monitor closely.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Norepinephrine can interact with other medications, influencing its efficacy or safety.

Major Interactions (Avoid)

  • MAO inhibitors: risk of hypertensive crisis.
  • Tricyclic antidepressants: additive pressor effects.
  • Phentolamine: antagonizes norepinephrine’s vasoconstriction.

Moderate Interactions (Monitor Closely)

  • Vasodilators (e.g., nitroglycerin): may require higher norepinephrine doses.
  • ACE inhibitors: can blunt blood‑pressure response.
  • Calcium‑channel blockers: may enhance hypotensive episodes.
  • Diuretics: volume depletion can amplify pressor needs.

Frequently Asked Questions

Noradrenalin Kalceks contains norepinephrine, a vasopressor used in hospital settings to treat acute hypotension, septic shock, and to support circulation during cardiac arrest. It is administered intravenously to rapidly raise blood pressure and improve organ perfusion.

Norepinephrine stimulates alpha‑1 receptors, causing blood‑vessel constriction, and beta‑1 receptors, increasing heart‑muscle contractility and rate. This dual action raises systemic vascular resistance and cardiac output, helping to restore normal blood pressure in shock states.

The specific infusion rate and total dose are determined by the treating physician based on the patient’s hemodynamic status, target blood pressure, and response to therapy. Dosing is individualized and adjusted continuously during treatment.

Safety data for norepinephrine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

Enquiries are submitted via the product page at gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Norepinephrine is often preferred as a first‑line vasopressor because it provides strong alpha‑1 mediated vasoconstriction with modest beta‑1 cardiac stimulation. Compared with dopamine, it has a lower risk of tachyarrhythmias, and unlike phenylephrine, it also supports heart‑rate and contractility.

The product must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Before use, allow the solution to reach room temperature if required, and inspect for particulate matter or discoloration.

It is given as an intravenous infusion, typically through a central venous catheter. The infusion is started at a low rate and titrated to achieve the desired blood‑pressure target, with continuous hemodynamic monitoring throughout the therapy.

Serious risks include severe hypertension, myocardial ischemia, tissue necrosis at the infusion site, arrhythmias, and pulmonary edema. Prompt recognition and adjustment of the infusion rate, along with vigilant monitoring, are essential to mitigate these complications.

Norepinephrine is contraindicated in patients with known hypersensitivity to the product, uncorrected pheochromocytoma, or severe peripheral vascular disease where further vasoconstriction could cause tissue loss. Caution is also advised in patients with existing myocardial ischemia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Norepinephrine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT